⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CBLL News
CeriBell, Inc. Common Stock
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
globenewswire.com
CBLL
Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026
globenewswire.com
CBLL
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
globenewswire.com
CBLL
Form 8-K
sec.gov
CBLL
Ceribell Reports Second Quarter 2026 Financial Results
globenewswire.com
CBLL
Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
globenewswire.com
CBLL
Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
globenewswire.com
CBLL
Form 8-K
sec.gov
CBLL
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
globenewswire.com
CBLL
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
globenewswire.com
CBLL